Given that the functions of DGCR10, HAR1B, and SNHG18 are rarely studied in gliomas, the patients from the TCGA database were classified into high- and low-expression groups according to the median expression level of these three lncRNAs. The gene discussed is HAR1B; the disease is central nervous system cancer.